임상시험 관리 시스템(CTMS) 시장은 2023-2030년 연평균 13.5% 성장하여 2030년에는 35억 9,000만 달러에 달할 것으로 예측됩니다.
이 보고서는 임상시험 관리 시스템 시장 시나리오에 대한 광범위한 2차 연구와 1차 조사, 심층 분석을 통해 주요 산업 촉진요인, 저해요인, 과제 및 기회 분석으로 구성되어 있습니다. 임상시험 수 급증, 의료 IT 도입 증가, 정부 지원 증가가 시장 촉진요인으로 작용하고 있습니다. 또한, AI 기반 CTMS의 채택이 증가함에 따라 시장 확대를 위한 더 나은 성장 기회를 제공할 가능성이 높습니다. 또한, 통합 CTMS 솔루션의 증가 추세도 시장 성장을 촉진할 것으로 보입니다. 그러나 첨단 디지털 솔루션을 다룰 수 있는 숙련된 의료 전문가의 부족은 CTMS 시장 성장에 큰 도전이 되고 있습니다.
(참고 : 기타 최종사용자에는 병원, 학술기관, 동물 의료 기업 등이 포함된다)
Clinical Trial Management System (CTMS) Market Size, Share, Forecast, & Trends Analysis by Component (Software, Service), Type (Enterprise, Site), Mode of Delivery (Web, Cloud, On-premise), End User (CRO, Pharmaceutical & Biotech) - Global Forecast to 2030
The clinical trial management system market is expected to grow at a CAGR of 13.5% from 2023 to 2030 to reach $3.59 billion by 2030.
Succeeding extensive secondary and primary research and in-depth analysis of the clinical trial management system market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. A surge in the number of clinical trials, increasing adoption of healthcare IT, and rising government support are the factors driving the market growth. Furthermore, increasing the adoption of AI-based CTMS will likely offer better growth opportunities for market expansion. Moreover, the growing trend of integrated CTMS solutions is expected to support market growth. However, the lack of skilled healthcare professionals to handle advanced digital solutions poses a major challenge to the growth of the CTMS market.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2023). The key players operating in the global clinical trial management system (CTMS) market are Oracle Corporation (U.S.), SimpleTrials (U.S.), LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.), Wipro Limited (India), Advarra, Inc. (U.S.), RealTime Software Solutions, LLC (U.S.), Datatrak International, Inc. (U.S.), Clario (U.S.), Dassault Systemes (France), Veeva Systems Inc. (U.S.), PHARMASEAL (U.K.), MasterControl Inc. (U.S.), Calyx (U.S.), IQVIA HOLDINGS INC. (U.S.), and DSG, Inc. (U.S.) among others.
Based on component, the software segment is expected to account for the largest share of the market in 2023. The factors contributing to the largest share of the market are ease in establishing regulatory compliance in clinical trials, rising research & development expenditure, and effective management of clinical trials leading to increased adoption of the clinical trial management system (CTMS).
Based on type, the market is segmented into enterprise-based and site-based CTMS. The enterprise-based segment is expected to account for the largest share of the market in 2023, owing to advantages such as end-to-end insights into operational activities, reduction in cost and investment, and adaption to advanced processes due to control and connection within the organization.
Based on end user, the market is segmented into pharmaceutical & biotechnology companies, medical device companies, contract research organizations, and other end users. The contract research organization segment is expected to account for the largest share of the market in 2023. Companies tend to outsource their clinical trial operations as they are complex and require time and investment. The large share can be attributed to the increased outsourcing of clinical trials by various healthcare stakeholders, including pharmaceutical & biotechnology companies, medical device manufacturers, animal health companies, and a few academic institutes.
An in-depth analysis of the geographical scenario of the global clinical trial management system (CTMS) market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.
Asia-Pacific is estimated to grow at the highest CAGR during the forecast period. Increasing outsourcing of clinical trials by major and minor stakeholders, the rising number of clinical trials in the region, and the availability of a large patient pool drive the demand for clinical trial management systems (CTMS).
Global Clinical Trial Management System (CTMS) Market, by Component
Global Clinical Trial Management System (CTMS) Market, by Type
Global Clinical Trial Management System (CTMS) Market, by Mode of Delivery
Global Clinical Trial Management System (CTMS) Market, by End User
(Note: Other end users include hospitals, academic institutions, and animal health companies, among others)
Global Clinical Trial Management System (CTMS) Market, by Geography
(Note: Other end users include hospitals, academic Institutions, and animal health companies, among others)